Navigation Links
Breast cancer mortality has not declined in women over 85
Date:1/16/2013

Since 1992 the number of deaths linked to breast cancer in Spain has decreased among young and middle aged patients but not among the elderly. Spanish researchers also predict that it will continue to decline over the next decade, although more slowly as observed up until now.

A new study headed by a team of Spanish researchers has analysed breast cancer mortality in Spain among different age groups from 1981 to 2007, setting a valid prediction up until 2023.

Studying this age-related tendency is interesting because any improvement could have significant social and economic consequences, especially in terms of the development of specific health plans.

"We used the Lee-Carter model to examine the data. This model is normally used to study general mortality but rarely employed to study mortality as a result of specific causes," as explained to SINC by Alejandro lvaro Meca, lead author of the study and researcher at the department of Preventative Medicine and Public Health at the Rey Juan Carlos University in Madrid.

Published in the 'Public Health' journal, the results confirm that associated mortality increased with age, whereas in the different age groups it has decreased over time. The study shows an increase in breast cancer mortality in Spain from 1981 to 1992 and then a decrease from 1993 to 2007.

This could be due to the global increase in mammographies in women over the age of 45, which has increased early diagnosis and improved survival rates as a result.

"The new results support this assumption: there is an evident decrease in breast cancer mortality in women under the age of 50," state the authors.

A slower decrease for the future

The last stage of the Lee-Carter model involves predicting mortality in the future: up until 2023 in this case. lvaro Meca suggests that the death rate will decrease but will not be so marked as in the past.

"Predictions show that rates will decrease more slowly. Mortality will decrease in all age groups but will not be the same for all. A more significant decrease will be observed amongst the youngest women, with a great difference in middle aged women where stabilisation is predicted and then even an increase amongst elderly women (85 years or over)," adds the researcher.

The results fall in line with those of other studies conducted in Spain. However, research studying mortality in age groups is still scarce.

"Although this decrease trend will continue into the future, everything points to a stabilisation in mortality for elderly women," points out lvaro Meca. "Therefore, breast cancer preventative practices should be different and specific to the age range of the patient," he concludes.

The reason behind this tendency

Breast cancer incidence has increased in all European countries in recent years, independently of whether or not national screening programmes are in place. However, mortality has experienced an annual decrease of 1.8% from 1997 to 2006.

This tendency is due to mammographies and the application of effective hormone treatments, chemotherapy and advances in radiotherapy and surgery.

According to Spain's 2006 National Health Survey, 4% of women between the age of 25 and 34 and 19% between the age of 35 and 44 undergo a mammography every two years.

"It is probable that such innovation has contributed to improved breast cancer survival rates observed in Europe, although the contribution of each factor is unknown," indicate the authors.


'/>"/>

Contact: Press Office
info@agenciasinc.es
34-914-251-820
FECYT - Spanish Foundation for Science and Technology
Source:Eurekalert  

Related medicine news :

1. Dr. Sam Speron Tips On How People Can Spot Breast Implants
2. Fox Chase researchers discover novel role of the NEDD9 gene in early stages of breast cancer
3. Researchers reveal aggressive breast cancers metastatic path
4. Breast Milk Contains More Than 700 Bacteria Types: Study
5. Costly breast cancer screenings dont add up to better outcomes
6. Costly Breast Cancer Screenings May Not Help Seniors: Study
7. Breastfeeding tips women share intrigue doctors
8. Boost Your Bust: Review Examining Jenny Bolton's Breast Enlargement System Released by HonestyFirstReviews.com
9. Breast milk contains more than 700 bacteria
10. PET/CT shows clear advantages over conventional staging for breast cancer patients
11. PRMA Pink Ladies Gaining Members Across the Country Through Monthly Live Internet Meetings, Offering Support and Inspiration to Breast Cancer Survivors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Breast cancer mortality has not declined in women over 85
(Date:9/21/2017)... , ... September 21, 2017 , ... ... learn with Infinity Behavioral Health Services for professionals in the addiction treatment industry ... Payer Audit . , Insurance companies and state and federal governments are ...
(Date:9/21/2017)... ... 2017 , ... Hair restoration surgery is having a moment, ... International Society of Hair Restoration Surgery (ISHRS). The worldwide volume of ... 635,189 procedures performed in 2016. , "Like other forms of cosmetic surgery ...
(Date:9/21/2017)... San Diego, Ca (PRWEB) , ... September 21, 2017 , ... ... and affordable services to its customers, and give back to the community. For over ... on of the most successful companies serving plumbing in San Diego. They ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... ... using Microscan’s LVS 7510 at the Global GS1 Healthcare Conference 2017 in Chicago, ... the life-sciences industry for ensuring label quality and improving patient safety. , ...
(Date:9/21/2017)... ... September 21, 2017 , ... Preora Diagnostics Inc. , ... tests, has received two prestigious recognitions that acknowledge the promise of its PWS ... Preora has been named a Top 100 Finalist for the 16th annual Chicago ...
Breaking Medicine News(10 mins):
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform ... leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 ... performance ratings for global supply chains, has published the first annual edition ... CSR performance of more than 20,400 companies evaluated by EcoVadis, based on ... 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
(Date:9/9/2017)... , Sept. 9, 2017  Eli Lilly and ... primary and secondary endpoint data for lasmiditan, an investigational, ... which demonstrated statistically significant improvements compared to placebo in ... highlighted today at the 18th Congress of the International ... "The data presented today demonstrate lasmiditan,s potential ...
Breaking Medicine Technology: